These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2093839)

  • 41. Efficacy of itraconazole in treating AIDS-associated infections due to Candida krusei.
    Coppola S; Angarano G; Montagna MT; Congedo P; Monno L; Bellisario A; Pastore G
    Eur J Epidemiol; 1995 Apr; 11(2):243-4. PubMed ID: 7672085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-albicans oral candidosis in HIV-positive patients.
    Cartledge JD; Midgley J; Gazzard BG
    J Antimicrob Chemother; 1999 Mar; 43(3):419-22. PubMed ID: 10223601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Fluconazole in therapy of candidiasis of the oropharyngeal space in patients with HIV infection. Results of an open multicenter study of assessing the effectiveness and tolerance of fluconazole].
    Tschechne B; Brunkhorst U; Ruhnke M; Trautmann M; Dempe S; Deicher H
    Med Klin (Munich); 1991 Oct; 86(10):508-11. PubMed ID: 1758372
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.
    Schuman P; Capps L; Peng G; Vazquez J; el-Sadr W; Goldman AI; Alston B; Besch CL; Vaughn A; Thompson MA; Cobb MN; Kerkering T; Sobel JD
    Ann Intern Med; 1997 May; 126(9):689-96. PubMed ID: 9139554
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oropharyngeal yeast flora and fluconazole resistance in HIV-infected patients receiving long-term continuous versus intermittent fluconazole therapy.
    Heald AE; Cox GM; Schell WA; Bartlett JA; Perfect JR
    AIDS; 1996 Mar; 10(3):263-8. PubMed ID: 8882665
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral Candida isolates among HIV-infected subjects in Nigeria.
    Nweze EI; Ogbonnaya UL
    J Microbiol Immunol Infect; 2011 Jun; 44(3):172-7. PubMed ID: 21524610
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral Candida albicans isolates with reduced susceptibility to fluconazole in Swedish HIV-infected patients.
    Chryssanthou E; Torssander J; Petrini B
    Scand J Infect Dis; 1995; 27(4):391-5. PubMed ID: 8658076
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis.
    Redding S; Smith J; Farinacci G; Rinaldi M; Fothergill A; Rhine-Chalberg J; Pfaller M
    Clin Infect Dis; 1994 Feb; 18(2):240-2. PubMed ID: 8161633
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer.
    Groll AH; Just-Nuebling G; Kurz M; Mueller C; Nowak-Goettl U; Schwabe D; Shah PM; Kornhuber B
    J Antimicrob Chemother; 1997 Dec; 40(6):855-62. PubMed ID: 9462438
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fluconazole sensitivities of Candida species isolated from the mouths of terminally ill cancer patients.
    Ball K; Sweeney MP; Baxter WP; Bagg J
    Am J Hosp Palliat Care; 1998; 15(6):315-9. PubMed ID: 9866454
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children. Multicentre Study Group.
    Hernández-Sampelayo T
    Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):340-4. PubMed ID: 8070443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Study of acute vulvovaginitis in sexually active adult women, with special reference to candidosis, in patients of the Francisco J. Muñiz Infectious Diseases Hospital].
    Buscemi L; Arechavala A; Negroni R
    Rev Iberoam Micol; 2004 Dec; 21(4):177-81. PubMed ID: 15709796
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis.
    Villanueva A; Gotuzzo E; Arathoon EG; Noriega LM; Kartsonis NA; Lupinacci RJ; Smietana JM; DiNubile MJ; Sable CA
    Am J Med; 2002 Sep; 113(4):294-9. PubMed ID: 12361815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of fluconazole in the treatment of upper gastrointestinal candidiasis in neutropenic patients with cancer: factors influencing the outcome.
    Akova M; Akalin HE; Uzun O; Hayran M; Tekuzman G; Kansu E; Aslan S; Telatar H
    Clin Infect Dis; 1994 Mar; 18(3):298-304. PubMed ID: 8011807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Candida humicola infection of the central nervous system in an HIV-infected patient: a case report].
    Rogowska-Szadkowska D; Wiercińska-Drapało A; Borzuchowska A; Prokopowicz D
    Przegl Epidemiol; 1997; 51(4):465-9. PubMed ID: 9562797
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral colonization by yeasts in HIV-positive patients in Brazil.
    Junqueira JC; Vilela SF; Rossoni RD; Barbosa JO; Costa AC; Rasteiro VM; Suleiman JM; Jorge AO
    Rev Inst Med Trop Sao Paulo; 2012; 54(1):17-24. PubMed ID: 22370749
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily.
    Stevens DA; Greene SI; Lang OS
    Arch Intern Med; 1991 Dec; 151(12):2458-64. PubMed ID: 1747004
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295.
    Fichtenbaum CJ; Zackin R; Rajicic N; Powderly WG; Wheat LJ; Zingman BS
    AIDS; 2000 May; 14(7):845-52. PubMed ID: 10839593
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Yeast infections: causative agents and their antifungal resistance in hospitalized pediatric patients and HIV-positive adults].
    Rodero L; Boutureira M; Demkura H; Burkett A; Fernández C; Losso M; Jáuregui Rueda H; Monticelli A; Vitale R; Canteros C; Hochenfellner F; Vivot W; Davel G
    Rev Argent Microbiol; 1997; 29(1):7-15. PubMed ID: 9229726
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oropharyngeal yeast colonization in HIV-infected outpatients in southern Taiwan: CD4 count, efavirenz therapy and intravenous drug use matter.
    Wu CJ; Lee HC; Yang YL; Chang CM; Chen HT; Lin CC; Lee NY; Chu WL; Hsieh LY; Wang YL; Lauderale TL; Tseng FC; Ko NY; Ko WC; Lo HJ
    Clin Microbiol Infect; 2012 May; 18(5):485-90. PubMed ID: 21939471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.